Literature DB >> 33420577

Effect of parathyroidectomy on renal stone recurrence.

Pierre-Yves Charles1, Emmanuel Letavernier1,2, Sophie Périé3, Mathieu Gauthé4, Michel Daudon1,2, Jean-Philippe Haymann5,6.   

Abstract

Parathyroidectomy (PTX) is routinely performed in hypercalciuric renal stone patients with primary hyperparathyroidism (PHPT). However, some data indicate a persistent stone activity following PTX, raising the issue of the link between PHPT and stone disease. We performed an observational study on 30 renal stone patients diagnosed with PHPT. Patients were selected among 1448 hypercalciuric patients referred in our department for a diagnostic evaluation. Patients with no parathyroid surgery or any biological follow-up were excluded. Clinical and biological data (including 24-h urine collection and a calcium load test) were collected before and within 12 months following surgery. Stone recurrence was evaluated by direct phone contact (median 43 months). Comparison of biological data before and after surgery showed a significant decrease of ionized calcium and serum parathyroid hormone after PTX. All stones contained calcium-dependent species such as carbapatite, brushite or dihydrate calcium oxalate. Urine saturation indexes and calciuria significantly decreased after surgery (from 9.9 to 5.9 mmol/d, p < 0.0001), but a persistent hypercalciuria was detected in 47% of patients. The other stone risk factors including diuresis stayed similar. Stone activity that was increasing (from 0.20-0.30 to 0.50-0.75/year) the 2 years before PTX, significantly decreased after surgery [0.05-0.15/year (p < 0.001)]. PTX in calcium-dependent renal stone formers with PHPT significantly decreases both stone recurrence and urine saturation indexes. However, PTX unmasked an underlying renal stone disease related to idiopathic hypercalciuria in half of patients with a remaining stone activity, testifying the need for patient's follow-up to prevent stone recurrence.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature.

Entities:  

Keywords:  Calciuria; Parathyroidectomy; Primary hyperparathyroidism; Renal stone

Mesh:

Year:  2021        PMID: 33420577     DOI: 10.1007/s00240-020-01239-x

Source DB:  PubMed          Journal:  Urolithiasis        ISSN: 2194-7228            Impact factor:   3.436


  22 in total

1.  Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop.

Authors:  John P Bilezikian; Aliya A Khan; John T Potts
Journal:  J Clin Endocrinol Metab       Date:  2009-02       Impact factor: 5.958

2.  Renal stones and calcifications in patients with primary hyperparathyroidism: associations with biochemical variables.

Authors:  Jakob Starup-Linde; Elin Waldhauer; Lars Rolighed; Leif Mosekilde; Peter Vestergaard
Journal:  Eur J Endocrinol       Date:  2012-04-03       Impact factor: 6.664

3.  Persistence of hypercalciuria after successful surgical treatment for primary hyperparathyroidism.

Authors:  Francisco Rodolfo Spivacow; Armando Luis Negri; Elisa Elena del Valle; Erich Fradinger; Carolina Martinez; Ana Polonsky
Journal:  Int Urol Nephrol       Date:  2011-04-20       Impact factor: 2.370

4.  Primary hyperparathyroidism: renal calcium excretion in patients with and without renal stone sisease before and after parathyroidectomy.

Authors:  Vibe G Frøkjaer; Charlotte L Mollerup
Journal:  World J Surg       Date:  2002-02-19       Impact factor: 3.352

5.  Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidism.

Authors:  Joan H Parks; Fredric L Coe; Andrew P Evan; Elaine M Worcester
Journal:  BJU Int       Date:  2008-09-12       Impact factor: 5.588

6.  The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years.

Authors:  Mishaela R Rubin; John P Bilezikian; Donald J McMahon; Thomas Jacobs; Elizabeth Shane; Ethel Siris; Julia Udesky; Shonni J Silverberg
Journal:  J Clin Endocrinol Metab       Date:  2008-06-10       Impact factor: 5.958

7.  The accuracy of parathyroid gland localization in primary hyperparathyroidism using sestamibi radionuclide imaging.

Authors:  L B Johnston; M J Carroll; K E Britton; D G Lowe; W Shand; G M Besser; A B Grossman
Journal:  J Clin Endocrinol Metab       Date:  1996-01       Impact factor: 5.958

8.  Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop.

Authors:  John P Bilezikian; Maria Luisa Brandi; Richard Eastell; Shonni J Silverberg; Robert Udelsman; Claudio Marcocci; John T Potts
Journal:  J Clin Endocrinol Metab       Date:  2014-08-27       Impact factor: 5.958

9.  Is parathyroidectomy of benefit in primary hyperparathyroidism?

Authors:  S Posen; P Clifton-Bligh; T S Reeve; C Wagstaffe; M Wilkinson
Journal:  Q J Med       Date:  1985-03

10.  Biochemical characterization of primary hyperparathyroidism with and without kidney stones.

Authors:  Clarita V Odvina; Khashayar Sakhaee; Howard J Heller; Roy D Peterson; John R Poindexter; Paulette K Padalino; Charles Y C Pak
Journal:  Urol Res       Date:  2007-05-03
View more
  2 in total

1.  Persistent hypercalciuria after parathyroidectomy.

Authors:  Rebecca Tregunna
Journal:  Nat Rev Urol       Date:  2021-04       Impact factor: 14.432

2.  Development and validation of a nomogram for risk prediction of nephrolithiasis recurrence in patients with primary hyperparathyroidism.

Authors:  Yihong Zhou; Xi Chu; Dong Jiang; Xiang Wu; Jiarong Xu; Hao Qi; Yuxin Tang; Yingbo Dai
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-31       Impact factor: 6.055

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.